8-K: cbdMD to acquire Twinlab brands, lifting trailing revenue to about $30 million

cbdMD entered a definitive asset purchase agreement to acquire Twinlab operating assets and brands, including Twinlab, Reserveage, Metabolife, and Alvita Tea, through an assignment for the benefit of creditors proceeding. Based on unaudited financial information, combined trailing twelve months revenue ending June 2026 totals approximately $30 million, an increase of approximately 40% relative to cbdMD standalone revenue for the same period. The transaction is expected to reduce cbdMD’s revenue concentration in hemp and add retail reach across roughly 50,000 outlets, including Vitamin Shoppe and GNC. Closing remains subject to court approval and customary conditions.

cbdMD entered a definitive asset purchase agreement to acquire Twinlab operating assets and brands, including Twinlab, Reserveage, Metabolife, and Alvita Tea, through an assignment for the benefit of creditors proceeding. Based on unaudited financial information, combined trailing twelve months revenue ending June 2026 totals approximately $30 million, an increase of approximately 40% relative to cbdMD standalone revenue for the same period. The transaction is expected to reduce cbdMD’s revenue concentration in hemp and add retail reach across roughly 50,000 outlets, including Vitamin Shoppe and GNC. Closing remains subject to court approval and customary conditions.